Oxidative stress and metabolism in animal model of colitis induced by dextran sulfate sodium

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 11, 2007, Pages 1846-1851

  Damiani, Carlos R ^a   Benetton, César A F ^a   Stoffel, Cristhopher ^a   Bardini, Katrine C ^a   Cardoso, Vilson H ^a   Di Giunta, Gabriela ^a   Pinho, Ricardo A ^a   Dal Pizzol, Felipe ^a   Streck, Emilio L ^a  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

Author keywords

Colitis; Deferoxamine; Dextran sulfate sodium; N acetylcysteine; Oxidative stress; Respiratory chain

Indexed keywords

ACETYLCYSTEINE; CYTOCHROME C OXIDASE; DEFEROXAMINE; DEXTRAN SULFATE; SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE (UBIQUINONE); THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; DRUG EFFECT; HISTOPATHOLOGY; INFLAMMATION; INTESTINE PARAMETERS; LEUKOCYTE COUNT; MALE; METABOLISM; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CARBONYLATION; RAT;

EID: 34948892524     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2007.04890.x     Document Type: Article

References (23)

1. Dong WG, Liu SP, Yu BP, Wu DF, Luo HS, Yu JP. Ameliorative effects of sodium ferulate on experimental colitis and their mechanisms in rats. World J. Gastroenterol. 2003 9 : 2533 8.
2. Cetinkaya A, Bulbuloglu E, Kurutas EB, Ciralik H, Kantarceken B, Buyukbese MA. Beneficial effects of N-acetylcysteine on acetic-acid induced colitis in rats. Tohoku J. Exp. Med. 2005 206 : 131 9.
3. Reifen R, Nissenkorn A, Matas Z, Bujanover Y. 5-ASA and lycopene decrease the oxidative stress and inflammation induced by iron in rats with colitis. J. Gastroenterol. 2004 39 : 514 19.
4. Pearson DC, Jourd'heuil JB, Meddings JB. The anti-oxidant properties of 5-aminosalicylic acid. Free Rad. Biol. Med. 1996 21 : 367 73.
5. Yavuz Y, Yüksel M, Yegen BÇ, Alican I. The effect of antioxidant therapy on colonic inflammation in the rat. Res. Exp. Med. 1999 199 : 101 10.
6. Ahn BO, Ko KH, Oh TY et al. Efficacy of use of colonoscopy in dextran sulfate sodium induced ulcerative colitis in rats: the evaluation of the effects of antioxidant by colonoscopy. Int. J. Colorectal Dis. 2001 16 : 174 81.
7. Calabrese V, Scapagnini G, Giuffrida-Stella AM, Bates TE, Clark JB. Mitochondrial involvement in brain function and dysfunction: relevance to aging, neurodegenerative disorders and longevity. Neurochem. Res. 2001 26 : 739 64.
8. Seril DN, Liao J, Ho KL, Yang CS, Yang GY. Inhibition of chronic ulcerative colitis-associated colorectal adenocarcinoma development in a murine model by N-acetylcysteine. Carcinogenesis 2002 23 : 993 1001.
9. Sprong RC, Winkelhuyzen-Janssen AML, Aarsman CJM, Van Oirschot JF, Van der Bruggen T, Van Asbeck BS. Low-dose N-acetylcysteine protects rats against endotoxin-mediated oxidative stress, but high-dose increases mortality. Am. J. Respir. Crit. Care Med. 1998 157 : 1283 93.
10. Vulcano M, Meiss RP, Isturiz MA. Deferoxamine reduces tissue injury and lethality in LPS-treated mice. Int. J. Immunopharmacol. 2000 22 : 635 44.
11. Ritter C, Andrades ME, Reinke A, Menna-Barreto S, Moreira JC, Dal-Pizzol F. Treatment with N-acetylcysteine plus deferoxamine protects rats against oxidative stress and improves survival in sepsis. Crit. Care Med. 2004 32 : 342 9.
12. Ritter C, Reinke A, Andrades M et al. Protective effect of N-acetylcysteine and deferoxamine on carbon tetrachloride-induced acute hepatic failure in rats. Crit. Care Med. 2004 32 : 2079 83.
13. Ritter C, Cunha AA, Echer IC et al. Effects of N-acetylcysteine plus deferoxamine in lipopolysaccharide-induced acute lung injury in the rat. Crit. Care Med. 2006 34 : 471 7.
14. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951 193 : 265 7.
15. Wallace JL, Braquet P, Ibbotson GC, MacNoughton WK, Cirino G. Assessment of the role of platelet activating factor in an animal model of inflammatory bowel disease. J. Lipid Med. 1989 1 : 13 23.
16. Gue M, Bonbonne C, Fioramonti J et al. Stress-induced enhancement of colitis in rats: CRF and arginine vasopressin are not involved. Am. J. Physiol. 1997 272 : 84 91.
17. Fischer JC, Ruitenbeek W, Berden JA et al. Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clin. Chim. Acta 1985 153 : 23 6.
18. Rustin P, Chretien D, Bourgeron T et al. Biochemical and molecular investigations in respiratory chain deficiencies. Clin. Chim. Acta 1994 228 : 35 51.
19. Draper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol. 1990 186 : 421 31.
20. Levine RL, Garland D, Oliver CN. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990 186 : 464 78.
21. Millar AD, Rampton DS, Blake DR. Effects of iron and iron chelation in vitro on mucosal oxidant activity in ulcerative colitis. Aliment. Pharmacol. Ther. 2000 14 : 1163 8.
22. Barollo M, D'Inca R, Scarpa M et al. Effects of iron deprivation or chelation on DNA damage in experimental colitis. Int. J. Colorectal Dis. 2004 19 : 461 6.
23. Koksoy FN, Kose H, Soybir GR, Yalcin O, Cokneseli B. The prophylactic effects of superoxide dismutase, catalase, desferrioxamine, verapamil and disulfiram in experimental colitis. J. R. Coll. Surg. Edinb. 1997 42 : 27 30.